Effects of H2-receptor antagonists on dapsone-induced methaemoglobinaemia in rats

Pharmacological Research

Volumn 45, Issue 4, 2002, Pages 269-273

  Malfaré, Wilson Roberto ^a   Pereira, Carolina Paula ^a   Dos Santos, Antonio Cardozo ^a   Costa Queiroz, Regina Helena ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Cimetidine; Dapsone; Famotidine; Methaemoglobinaemia; Ranitidine; Rat

Indexed keywords

ACETYLDAPSONE; CIMETIDINE; CYTOCHROME P450; DAPSONE; ETHER; FAMOTIDINE; HISTAMINE H2 RECEPTOR ANTAGONIST; RANITIDINE;

ACETYLATION; ANESTHESIA; ANIMAL MODEL; ANIMAL TISSUE; AORTA; ARTICLE; BINDING AFFINITY; BLOOD ANALYSIS; BLOOD SAMPLING; CONTROLLED STUDY; DETOXIFICATION; DRUG ACTIVITY; DRUG BINDING; DRUG BLOOD LEVEL; DRUG POTENTIATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MALE; METHEMOGLOBINEMIA; NONHUMAN; PRIORITY JOURNAL; RAT; SPECTROPHOTOMETRY; TOXICOLOGY;

EID: 0036448104     PISSN: 10436618     EISSN: None     Source Type: Journal    
DOI: 10.1006/phrs.2002.0958     Document Type: Article

References (33)

1. Coleman MD, Scott AK, Breckenridge AM, Park BK. The use of cimetidine as a selective inhibitor of dapsone N-hydroxylation in man. Br J Clin Pharmacol 1990; 30: 761-7.
2. Coleman MD, Tingle MD, Park BK. Inhibition of dapsone-induced methaemoglobinaemia by cimetidine in the rat during chronic dapsone administration. J Pharm Pharmacol 1991; 43: 186-90.
3. Coleman MD, Hoaksey PE, Breckenridge AM, Park BK. Inhibition of dapsone induced methaemoglobinaemia in the rat isolated perfused liver. J Pharm Pharmacol 1990; 42: 302-7.
4. Edstein MD, Rieckmann KH, Veenendaal JR. Multiple-dose pharmacokinetics and in vitro antimalarial activity of dapsone plus pyrimethamine (Maloprim©) in man. Br J Clin Pharmacol 1990; 30: 259-65.
5. Podzamczer D, Martos A, Ferrer I, Santin M, Gudiol F. Hepatic and pulmonary pneumocystosis during primary prophylaxis for Pneumocystis carinii pneumonia with dapsone/pyrimethamine. Clin Infect Dis 1993; 16: 171.
6. Sin DD, Shafran SD. Dapsone and primaquine induced methe-moglobinemia in HIV infected individuals. J Acquir Immune Defic Syndr Hum Retroviral 1996; 12: 477-81.
7. Coleman MD. Dapsone: Modes of action, toxicity and possible strategies for increasing patient tolerance. Br J Dermatol 1993; 129: 507-13.
8. Coleman MD. Dapsone toxicity: Some current perspectives. Gen Pharmacol 1995; 26: 1461-7.
9. De Felice R, Johnson DG, Galgiani JN. Gynecomastia with ketoconazole. Antimicrob Agents Chemother 1981; 19: 1073-4.
10. Edstein MD, Rieckmann KH, Veenendaal JR. Multiple-dose pharmacokinetics and in vitro antimalarial activity of dapsone plus pyrimethamine (Maloprim®) in man. Br J Clin Pharmacol 1990; 30: 259-65.
11. Grossman S, Budinsky R, Jollow D. Dapsone-induced hemolytic anemia: Role of glucose-6-phosfate dehydrogenase in the hemolytic response of rat erythrocytes to N-hydroxydapsone. Am Soc Pharmacol Exp Ther 1995; 273: 870-7.
12. Harrison HJ, Jollow JD. Role of aniline metabolites in aniline-induced hemolytic anemia. J Pharmacol Exp Ther 1992; 238: 1045-54.
13. Tingle MD, Coleman MD, Park BK. The effect of preincubation with cimetidine on the N-hydroxylation of dapsone by human liver microssomes. Br J Clin Pharmacol 1991; 32: 120-3.
14. Lewis JH. Hepatic effects of drugs used in the treatment of peptic ulcer disease. Am J Gastroenterol 1987; 82: 987-1003.
15. Puurunen J, Pelkonen O. Cimetidine inhibits microssomal drug metabolism in the rat. Eur J Pharmacol 1979; 55: 335-6.
16. Rendic S, Kajfez F, Ruff H-H. Characterization of cimetidine, ranitidine, and related structures' interaction with cytochrome P-450. Drug Metab Disp 1983; 11: 137-42.
17. Breen KJ, Bury R, Desmond PV et al. Effects of cimetidine and ranitidine on hepatic drug metabolism. Clin Pharmacol Ther 1982; 31: 297-300.
18. Berardi RR, Tankanow RM, Nostrant TT. Comparison of famotidine with cimetidine and ranitidine. Clin Pharm 1988; 7: 271-84.
19. Lewis JH. Hepatic effects of drugs used in the treatment of peptic ulcer disease. Am J Gastroenterol 1987; 82: 987-1003.
20. Dresser GK, Spence JD, Bailey DG. Pharmacokinetic-pharmacodynamic consequences and clinical relevance of cytochrome P450 3A4 inhibition. Clin Pharmacokinet 2000; 38: 41-57.
21. Humphries TJ. Famotidine: a notable lack of drug interactions. Scand J Gastroenterol 1987; 134(Suppl.): 55-60.
22. Levine M, Bewllward GD. Effect of cimetidine on hepatic cytochrome P450: Evidence for formation of a metabolite-intermediate complex. Drug Metab Dispos 1995; 23: 1407-11.
23. Queiroz RHC, Melchior R Jr, De Souza AM, Gouveia E, Barbosa JC, De Carvalho D. Haematological and biochemical alterations in leprosy patients already treated with dapsone and MDT. Pharm Acta Helv 1997; 72: 209-13.
24. Rhodes LE, Tingle MD, Park BK, Chu P, Verbov JL, Friedmann PS. Cimetidine improves the therapeutic/toxic ratio of dapsone in patients on chronic dapsone therapy. Br J Dermatol 1995; 132: 257-62.
25. McMillan DC, Jensen CB, Jollow DJ. Role of lipid peroxidation in dapsone-induced hemolytic anemia. J Pharmacol Exp Ther 1998; 287: 868-76.
26. Martine C, Albert C, Agundez JÁ, Herrero E, Carrillo JÁ, Marquez M, Benitez J, Ortiz JÁ. Comparative in vitro and in vivo inhibition of cytochrome P450 CYP1A2, CYP2D6, and CYP3A by H2-receptor antagonists. Clin Pharmacol Ther 1999; 65: 369-76.
27. Grossman SJ, Jollow DJ. Role of dapsone hydroxylamine in dapsone induced hemolytic anemia. J Pharmacol Exp Ther 1988; 244: 118-25.
28. Erstad BL. Dapsone-induced methemoglobinemia and haemolytic anaemia: Grand rounds. Clin Pharmacol 1992; 11: 800-5.
29. Gill HJ, Tingle MD, Park BK. N-Hydroxylation of dapsone by multiple enzymes of cytochrome P450: Implications for inhibition of haemotoxicity. Br J Clin Pharmacol 1995; 40: 531-8.
30. Kelly JW, Scott J, Sandland M, Van der Weyden MB, Marks R. Vitamin E and dapsone-induced hemolysis. Arch Dermatol 1984; 120: 1582-4.
31. Prussick R, Ali MA, Rosenthal D, Guyatt G. The protective effect of vitamin E on the hemolysis associated with dapsone treatment in patients with dermatitis herpetiformis. Arch Dermatol 1992; 128: 210-3.
32. Pixley JS, MacKintosh FR, Sahr EA, Zanjani ED. Mechanism of ranitidine associated anemia. Am J Med Sci 1989; 369-71.
33. Rotoli B, Formisano S, Alfinito F. Autoimune haemolytic anaemia associated with cimetidine. Lancet 1979; 2: 583.